- Info
- Significant Ownership
Significant Ownership of Ho Chi Sing
- Signature - Title
- /s/ Ho Chi Sing - Ho Chi Sing
- Location
- Hong Kong
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Ho Chi Sing.
Follow Filing Activity
Follow Ho Chi Sing and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Ho Chi Sing
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Shares, par value US$0.0001 per share | 4.8% | $754,405 | 992,638 | 0% | Zhou Quan | 30 Sep 2025 | |
| PONY | Pony AI Inc. | Class A ordinary shares, par value US$0.0005 per share | 4.3% | $343,510,641 | -$66,897,472 | 15,273,928 | -16% | IDG China Venture Capital Fund IV L.P. | 30 Sep 2025 |
Schedules 13D/G Reported by Ho Chi Sing:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.